Mr. Ismail is an AV Peer Review-Rated partner with the firm. He practices in the areas of product liability, insurance coverage, commercial and business tort litigation. He has represented clients in bench and jury trials, in state and federal courts, and in mediations and other proceedings.
In his product liability practice, Mr. Ismail has represented Pfizer Inc, Bayer, Wyeth, DENTSPLY, Perrigo, Intervet and Akzo Nobel in cases involving pharmaceutical drugs, medical devices and other medical, dental and veterinary products. He has defended clients against class action lawsuits in a variety of settings. In his insurance coverage practice, Mr. Ismail has represented insurers, including Zurich, AIG and Everest, as well as policyholders, including DENTSPLY, in coverage disputes. In his commercial and general civil litigation practice, Mr. Ismail has litigated business disputes on behalf of clients ranging from large corporations, including Pfizer Inc, Republic Services and Genesis Health Ventures, to a variety of smaller companies. On referral from pro bono organizations, Mr. Ismail has also represented indigent clients in a variety of proceedings.
Mr. Ismail began his legal career at Goodell DeVries in 1993, practicing in the areas of pharmaceutical liability and insurance coverage litigation. He left briefly to practice white-collar criminal litigation at Hogan & Hartson, LLP, but later returned to Goodell DeVries to focus on civil litigation. He has been a partner since 2004.
- Member, Character Committee of Court of Appeals of Maryland for the Sixth Appellate Circuit (2014 - Present)
- Member, Governor's Trial Courts Judicial Nominating Commission for the Fourteenth Judicial District, Baltimore City (2007 - 2015)
- Adjunct Professor (Advocacy), University of Baltimore School of Law (2011 - 2013)
Selected Cases and Decisions
- Wyoming Premium Farms, LLC v. Pfizer Inc, (D. Wyo. 2013). Granting Judgment on the pleadings based on federal preemption of state law claims relating to animal vaccines.
- Trice, Geary & Myers, LLC v. CAMICO Mut. Ins. Co., (4th Cir. 2011). Reversing summary judgment against client policyholder and directing entry of partial summary judgment in its favor regarding duty to defend.
- Federal Ins. Co. v. Dentsply Int’l, Inc., (M.D.Pa. 2007). Upholding position of client policyholder that excess insurance was triggered after application of collective trigger and single occurrence limit to underlying primary insurance coverage for multiple claims arising from product line failures.
- Pfizer Inc v. Stryker Corp., 348 F.Supp. 2d 131 (S.D.N.Y. 2004). Granting partial summary judgment entitling client manufacturer that divested specialty prosthetics business to multimillion-dollar indemnification from acquiring entity for post-divestiture products liability claims. (Of Counsel to Pfizer Inc)
- Arnold v. Intervet, Inc., 305 F.Supp.2d 548 (D.Md. 2003). Agreeing with client manufacturer of animal vaccines that plaintiffs’ tort claims were probably preempted but rejecting federal question jurisdiction because federal regulation extinguished, not created, causes of action.
- Co-author of book chapter on “Impact Of Insurance Policies On Product Litigation,” in Current Law, Strategies and Best Practices in Product Litigation (Pract. Law Inst., 2009).
- Twombly-Iqbal "Plausibility" and Maryland's Pleading Requirements, Maryland Appellate Blog (April 2017)